Myalept (Metreleptin)

Myalept (metreleptin) is a leptin replacement therapy used as a doctor-recommended adjunct to diet to treat problems caused by not having enough leptin (leptin deficiency) in individuals with generalized lipodystrophy (GL).

Limitations of Use:

• It is not known if this therapeutic drug is safe and effective when used for treating complications caused by partial lipodystrophy or for treating liver disease, including non-alcoholic steatohepatitis (NASH).
• This drug should not be used to treat individuals with HIV-related lipodystrophy or individuals with metabolic disease, including diabetes mellitus and hypertriglyceridemia, without signs or symptoms of congenital or acquired generalized lipodystrophy.

Recommended Dosage: The recommended daily dosages are administered as a subcutaneous injection (SC) once daily after the lyophilized cake is reconstituted with Bacteriostatic Water for Injection (BWFI) or preservative-free sterile Water for Injection (WFI).

• Body weight 40 kg or less: The starting recommended dose is 0.06 mg/kg/day. The dosage can be increased or decreased by 0.02 mg/kg to a maximum daily dose of 0.13 mg/kg.
• Males greater than 40 kg body weight: The starting recommended dose is 2.5 mg/day. The dosage can be increased or decreased by 1.25 mg to 2.5 mg/day to a maximum dose of 10 mg/day.
• Females greater than 40 kg body weight: The starting recommended dose is 5 mg/day. The dosage can be increased or decreased by 1.25 mg to 2.5 mg/day to a maximum dose of 10 mg/day.

• Treatment with Myalept 11.3 mg injection has been related to an increased risk of developing lymphoma, particularly in individuals with acquired generalized lipodystrophy. Regular doctor check-ups are necessary to find out any early signs of this serious condition.
• Taking this medicinal product with insulin or medications that increase insulin production can cause dangerously low blood sugar levels. Always check your blood sugar regularly and adjust medication doses only after consulting your doctor.
• Metreleptin 11.3 mg may lead to the formation of antibodies that could make the treatment less effective. This might also result in autoimmune complications, so doctors should monitor for any unusual symptoms during treatment.
• Some allergic reactions to Metreleptin, such as swelling, rash, or breathing problems, can occur. If you experience any of these symptoms, stop treatment immediately and contact a healthcare provider (HCP) for urgent care.
• This therapeutic drug contains benzyl alcohol, which can harm newborns or infants aged under 2 years. It is necessary to avoid using this medicinal product in babies unless absolutely required and under medical advice.
• The safety of Metreleptin during pregnancy is not known. Pregnant women should only use this medicine if the doctor believes the benefits are greater than the potential risks to the unborn baby.
• It is not known if this medicine passes into breast milk and affects nursing babies. Breastfeeding mothers should discuss the risks and benefits of using Metreleptin with their healthcare provider before making a decision.

What documents are required to import Myalept to India?

MYALEPT (metreleptin) for injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
A valid prescription from a qualified doctor.
Patients diagnostic reports
Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is Myalept available in India?

MYALEPT (metreleptin injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Myalept in India (Mumbai, Kolkata,
• Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

MYALEPT can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of MYALEPT (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Myalept 11 mg injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source MYALEPT (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Myalept®?

Metreleptin is a Generic Name for the trade name drug Myalept®.

What is the Manufacturer's Name of Myalept®?

Myalept® is manufactured by Amryt Pharmaceuticals, Inc.

Is Myalept® approved by the FDA?

Yes, Myalept® is approved by the FDA. Date of first approval: February 24, 2014.

What is the dosage and form of Myalept® supplied?

Myalept is supplied as a sterile, white, solid, lyophilized cake of 11.3 mg metreleptin per vial to deliver 5 mg per mL when reconstituted in 2.2 mL of BWFI or WFI.

What are the most common side effects of Myalept® injection?

The most common side effects of Myalept® are hypoglycemia, headache, abdominal pain, and decreased weight.

How much does Myalept® injection cost in India?

Prices of Myalept 11.3 mg may fluctuate over time because of market dynamics and regulatory changes. To get the most recent details on Myalept 11.3 mg injection cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Myalept® injection be available in SAARC countries?

Apart from Gulf countries, Myalept® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Myalept® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Myalept® injections online in India?

Yes, one can buy Myalept online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the legal supply of Myalept® injections through legal channels.

What are the storage conditions of Myalept® injections?

Store in the refrigerator at 36-46°F (2-8°C) and protected from light. Keep the vials in the carton when not in use. Do not freeze it.